Reach Us +1-504-608-239
Editor - German Gomez | Laboratory of Dr. David Cheresh at UC Sa | 18475
ISSN: 2577-0535

Journal of Cancer Clinical Trials
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

German Gomez

German Gomez
German Gomez
Project Scientist
Laboratory of Dr. David Cheresh at UC San Diego


German Gomez trained with Dr. Carol Kruse at the University of Colorado Health Sciences Center and consequently gained extensive research experience in the field of brain tumor immunology and immunotherapy. His post-doctoral training was with Drs. Frank Furnari and Webster Cavenee at the Ludwig of Institute for Cancer Research at UC San Diego. At the Ludwig Institute, he studied mutant EGFR regulation of microRNAs in high grade malignant gliomas as well as mechanisms of resistance to EGFR inhibitors in glioma. Currently, Dr. Gomez is a project scientist in the laboratory of Dr. David Cheresh at UC San Diego studying the mechanisms by which integrin signaling drives cancer stemness and resistance to EGFR inhibitors in tumors of epithelial origin.

Research Interest

Brain tumor immunology
Resistance to EGFR inhibitors in tumors of epithelial origin
Integrin signaling drives cancer stemness

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7